NewsSource: EClinCloud

EClinCloud Product Overview | CTMS · Clinical Trial Management System

3 min readEClinCloud Editorial Team
EClinCloud product overview | CTMS · Clinical Trial Management System news header image

Source: EClinCloud. Author: EClinCloud.

EClinCloud · Clinical Research AI Technology Company

CTMS · Clinical Trial Management System

Execution Efficiency ↑ · Management Quality ↑ · Project Transparency ↑

Clinical trial project management (CTMS) spans core operational areas including project planning, study sites, trial participants, quality, and costs, serving as an important platform for ensuring efficient execution and end-to-end project management.

EClinCloud CTMS is built around the full clinical research lifecycle, integrating risk-based quality management (RBQM), professional project management services, and AI capabilities to help sponsors achieve more efficient, transparent, and visible clinical project management.

01 Product Overview

EClinCloud CTMS (Clinical Trial Management System) is a project management system covering the full lifecycle of clinical trials. Centered on core operations including project, study site, trial participant, quality, and cost management, it enables real-time tracking, collaborative management, and risk monitoring throughout the project, helping sponsors improve execution efficiency, management quality, and transparency.

02 What We Offer

■ CTMS System

■ ECC ONE Mobile App

■ Managed Services

■ 1-on-1 Role-Based Hands-On Training

■ Support for Flexible Multi-System Integration

03 Unlocking New Value in Project Management with AI

One-Click CTMS Project Configuration

Quickly identifies project information using AI to automatically generate project configurations, significantly shortening the project startup preparation cycle, reducing configuration error risks, and advancing project configuration standardization.

Intelligent Report Text Review

Uses AI to automatically detect typos, missing characters or words, and common text errors in reports, assisting users in quickly completing content verification, reducing manual word-by-word proofreading workload, and improving report-writing efficiency and text accuracy.

"Linxiaofu" Role-Specific AI Agent Assistant

Identifies questions based on user role, provides guidance on system operations, business workflows, and frequently asked questions, and supports 24/7 online responses and multilingual service.

For more AI capabilities, contact us to learn more...

04 Why Choose EClinCloud CTMS

■ Lightweight customization to build a dedicated management platform

■ Partnering with users to co-build an RBQM risk management ecosystem

■ Providing professional CTMS managed services

■ Rapid response to build long-term partnerships

05 Value Demonstrated in Client Practice

Case 1: Efficient CTMS Project Data Migration

A pharmaceutical company needed to complete multi-project data migration within a limited timeframe because its previous CTMS system was about to be decommissioned. Focusing on core operational data such as study sites, trial participants, and progress, EClinCloud carried out schema mapping, data verification, and batch migration to ensure accurate project continuity and a smooth transition to the new system.

Case 2: Long-Term CTMS Managed Services

A biotech client entrusted its long-term CTMS managed services to EClinCloud. EClinCloud continuously optimizes system settings and usage rules as business needs evolve and responds promptly to adjustment requests. The client reported that day-to-day management requires less effort and that internal collaboration efficiency has improved markedly.

Integrated platform · Interconnected data

CTMSEDCeTMFeCOARTSMRMIRCeLearningScale managementRater training

📞 Contact us

Website: www.eclincloud.com

Email: ecc@eclincloud.com

Technological innovation to bring effective treatments to patients




About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, developing an AI-driven, integrated intelligent clinical cloud platform and endpoint assessment technologies. It provides global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug and medical device R&D cycles for the benefit of patients.







Article image

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.